In addition, HIF-1α hinders the transcriptional ability of c-myc, specifically by competing with c-myc to bind sp1, causing a certain degree of cell cycle arrest and decreasing the proliferation rate of tumor cells [103, 115]. Here, HIF1A is linked to neoplasm.